อายุรศาสตร์ จุฬาลงกรณ์ Chulalongkorn Internal Medicine

Cumedicine Board => CU Medicine Public Board => Topic started by: guendz on June 29, 2019, 04:11:04 PM

Title: ID conference on Tuesday July 2,2019
Post by: guendz on June 29, 2019, 04:11:04 PM
Journal: Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Fellow : Pattama T.

9.00 – 10.00 a.m.
I.D. Conference Room, 5th floor, Bhumisiri mangkhalanusorn building
For more, please visit http://www.idchula.org/
_____________________________

นพ.จิรวัฒน์ บุพพันเหรัญ

Jirawat Buppanharun, MD